NCT07573423

Brief Summary

This study is a randomized controlled trial designed to compare two commonly used skin closure techniques-linear closure and purse-string closure-after loop ileostomy reversal surgery. Surgical site infection (SSI) is one of the most frequent complications following stoma closure, leading to increased patient discomfort, prolonged hospital stay, and higher healthcare costs. In this trial, eligible adult patients undergoing elective loop ileostomy reversal are randomly assigned to either linear skin closure or purse-string skin closure. The purse-string technique leaves a small central opening that allows drainage, which may reduce infection risk, whereas linear closure involves complete approximation of the wound edges. All patients are managed according to standard hospital protocols and are followed during their hospital stay and for 30 days after surgery. The primary outcome is the occurrence of surgical site infection. Secondary outcomes include length of hospital stay and operative time. The purpose of this study is to determine which closure technique provides better outcomes in terms of reducing postoperative infections and improving recovery. The findings may help guide surgeons in selecting the most effective and safe method for skin closure after ileostomy reversal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 7, 2026

Completed
Last Updated

May 7, 2026

Status Verified

May 1, 2026

Enrollment Period

5 years

First QC Date

May 1, 2026

Last Update Submit

May 1, 2026

Conditions

Keywords

Surgical Site InfectionsPurse-string skin closureLinear skin closureWound closure techniquesPostoperative complicationsRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Surgical Site Infections Rate

    Proportion of participants who develop surgical site infection at the ileostomy reversal wound site, assessed using standard clinical criteria (redness, discharge, swelling, or pus).

    Within 30 days after surgery

Secondary Outcomes (1)

  • Length of Hospital Stay

    From surgery until hospital discharge (up to 7 days after surgery)

Study Arms (2)

Linear Skin Closure

ACTIVE COMPARATOR

Participants undergoing loop ileostomy reversal receive conventional linear skin closure with primary approximation of wound edges.

Procedure: Purse-String Skin Closure

Purse-String Skin Closure

ACTIVE COMPARATOR

Participants undergoing loop ileostomy reversal receive purse-string skin closure, leaving a small central opening to allow drainage.

Procedure: Linear Skin Closure

Interventions

Closure of the ileostomy reversal wound using conventional linear suturing with complete approximation of skin edges.

Purse-String Skin Closure

Closure of the ileostomy reversal wound using purse-string suturing technique, leaving a central gap for drainage to reduce infection risk.

Linear Skin Closure

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20 to 70 years
  • Both male and female patients
  • Patients undergoing elective loop ileostomy reversal
  • American Society of Anesthesiologists (ASA) physical status I-II
  • Patients who provide informed consent

You may not qualify if:

  • Patients with active stoma site infection (e.g., fever with total leukocyte count \>11,000/mm³)
  • Patients not planned for ileostomy reversal
  • Patients with severe comorbid conditions (ASA III or above)
  • Patients unwilling to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hayatabad Medical Complex

Peshawar, KPK, 25000, Pakistan

Location

Related Publications (4)

  • Ameer A, Mirza MB, Talat N. The Outcome of Purse-string Versus Conventional Wound Closure Techniques in Patients Undergoing Stoma Reversal: A Randomized Controlled Trial. J Pediatr Surg. 2024 Jun;59(6):1186-1189. doi: 10.1016/j.jpedsurg.2023.10.062. Epub 2023 Oct 30.

  • O'Leary DP, Carter M, Wijewardene D, Burton M, Waldron D, Condon E, Coffey JC, Peirce C. The effect of purse-string approximation versus linear approximation of ileostomy reversal wounds on morbidity rates and patient satisfaction: the 'STOMA' trial. Tech Coloproctol. 2017 Nov;21(11):863-868. doi: 10.1007/s10151-017-1713-x. Epub 2017 Nov 17.

  • Aga E, Keinan-Boker L, Eithan A, Mais T, Rabinovich A, Nassar F. Surgical site infections after abdominal surgery: incidence and risk factors. A prospective cohort study. Infect Dis (Lond). 2015;47(11):761-7. doi: 10.3109/23744235.2015.1055587. Epub 2015 Jun 26.

  • Nota SP, Braun Y, Ring D, Schwab JH. Incidence of surgical site infection after spine surgery: what is the impact of the definition of infection? Clin Orthop Relat Res. 2015 May;473(5):1612-9. doi: 10.1007/s11999-014-3933-y.

MeSH Terms

Conditions

Surgical Wound InfectionPostoperative Complications

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study in which neither participants nor care providers are blinded due to the nature of the surgical interventions. Outcome assessment is based on objective clinical criteria.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned in a 1:1 ratio to either linear skin closure (Group A) or purse-string skin closure (Group B) following loop ileostomy reversal. Both groups are followed prospectively to compare postoperative outcomes.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Surgeon Registrar

Study Record Dates

First Submitted

May 1, 2026

First Posted

May 7, 2026

Study Start

June 22, 2020

Primary Completion

July 1, 2025

Study Completion

July 31, 2025

Last Updated

May 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations